FEB 22, 2017 10:30 AM PST

NGS live in your lab in 30 days

C.E. CREDITS: P.A.C.E. CE | Florida CE
  • Associate Director, NGS
      Salim Essakali studied biology at Heinrich-Heine University, Düsseldorf, Germany and specialized in biomedicine. He conducted his Master's thesis at Peter MacCallum Cancer Center in Melbourne, Australia analyzing gene expression profiles in chronic lymphocytic leukemia. In October 2007, he joined the Global Product Management Team at QIAGEN in Hilden, Germany and has been responsible for managing multiple automated platforms and bioinformatics solutions
    • Product Director, QIAGEN
        Yi is currently a Product Director at QIAGEN, responsible for content and application development of Cancer Molecular Research and Diagnostics. She led efforts to develop and commercialize the GeneReader NGS System. She has years of experience working in the diagnostic and pharmaceutical industries, in various development, product management, marketing and strategic planning roles. She started her career as a biomedical scientist, having published many peer-reviewed articles and a diagnostics patent.


      Identification of the many complex genetic aberrations associated with cancers, and deciphering their role in disease progression and response to treatment is one of the major challenges faced by oncology researchers.   Next-Generation Sequencing has the potential to provide unprecedented insight into the complex molecular pathology of diseases such as cancer. However, broad adoption of NGS technology by small and medium sized laboratories can be daunting due to the inherent complexity of the technology, workflow fragmentation and cost obscurity, all of which lead to protracted investment of time and resources.


      The QIAGEN GeneReader NGS System was developed specifically with small to medium throughput laboratories in mind. The system is the world’s first truly Sample to Insight NGS workflow integrating all upstream sample processing steps, as well as downstream bioinformatics analysis and interpretation. It has the added benefit of the standardization offered by a single vendor workflow solution, and scalability options to fit laboratories individual throughput needs.  This is an all-in-one solution that enables any research lab to chart the complex cancer genetic map while also providing up-to-date information, curated in the QIAGEN world leading Knowledge base that can be used to guide result interpretation.


      In today’s webinar, Salim Essakali will highlight the benefits of a complete NGS system that can lead you from nucleic acid extraction, through sequencing template preparation and sequencing to analysis and interpretation of the data generated. 


      In the second part, Dr. Yi Kong will introduce the new QIAGEN program ‘NGS live in your lab in 30 days’.  She will also share some of the experiences and data generated by early adopters of the GeneReader NGS System from around the globe.  


      Show Resources
      Loading Comments...